Rufeng Ma
Impact in
-
- Traditional Chinese Medicine Analysis
- Pharmacology top 2%
- Medicinal Plant Pharmacodynamics Research
- Pharmacological Effects of Natural Compounds
Papers in
-
- Bone Metabolism and Diseases 10
- Natural product bioactivities and synthesis 2
- Medicinal Plants and Bioactive Compounds 2
-
- Biomarkers in Disease Mechanisms 3
- Co-authors
- Dongwei Zhang (19 shared papers)Gao S (16 shared papers)Ruyuan Zhu (13 shared papers)Jianzhao Niu (11 shared papers)Chenyue Liu (12 shared papers)Min Fu (5 shared papers)Beibei Chen (9 shared papers)Min Fu (8 shared papers)
- Journals
- Frontiers in Pharmacology (2 papers)Cellular Physiology and Biochemistry (2 papers)BioMed Research International (2 papers)Phytotherapy Research (2 papers)Current Pharmaceutical Design (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Rufeng Ma
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 125
- Complementary and alternative medicine 162
- Pharmacology 167
- Biochemistry 62
- Orthopedics and Sports Medicine 70
- Molecular Medicine 41
Countries citing papers authored by Rufeng Ma
This map shows the geographic impact of Rufeng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufeng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufeng Ma more than expected).
Fields of papers citing papers by Rufeng Ma
This network shows the impact of papers produced by Rufeng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufeng Ma. The network helps show where Rufeng Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Rufeng Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 252 | |
| 2 | 2016 | 196 | |
| 3 | 2017 | 147 | |
| 4 | 2017 | 111 | |
| 5 | 2015 | 93 | |
| 6 | 2017 | 76 | |
| 7 | 2017 | 61 | |
| 8 | 2016 | 56 | |
| 9 | 2017 | 55 | |
| 10 | 2017 | 44 | |
| 11 | 2017 | 42 | |
| 12 | 2016 | 37 | |
| 13 | 2018 | 34 | |
| 14 | 2021 | 31 | |
| 15 | 2018 | 23 | |
| 16 | 2018 | 18 | |
| 17 | 2020 | 17 | |
| 18 | 2020 | 13 | |
| 19 | 2019 | 12 | |
| 20 | 2021 | 10 |
About Rufeng Ma
Rufeng Ma is a scholar working on Molecular Biology, Immunology, Epidemiology, Physiology and Pharmacology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (10 papers), Adipose Tissue and Metabolism (4 papers), Biomarkers in Disease Mechanisms (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Bone and Dental Protein Studies (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers), Natural product bioactivities and synthesis (2 papers) and Medicinal Plants and Bioactive Compounds (2 papers). The work is most often cited by research in Complementary and alternative medicine (162 citations), Pharmacology (167 citations), Biochemistry (62 citations), Orthopedics and Sports Medicine (70 citations) and Molecular Medicine (41 citations). Rufeng Ma has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Dongwei Zhang, Gao S, Ruyuan Zhu, Jianzhao Niu, Chenyue Liu, Min Fu, Beibei Chen, Min Fu, Yubo Guo and Lili Wang. Their work appears in journals such as Frontiers in Pharmacology, Cellular Physiology and Biochemistry, BioMed Research International, Phytotherapy Research and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.